Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-10-01
著者
-
BABAZONO Tetsuya
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of
-
Babazono Tetsuya
Division Of Nephrology And Hypertension Department Of Medicine Diabetes Center Tokyo Women's Me
-
Iwamoto Yasuhiko
Department Of Medicine Diabetes Center Tokyo Women's Medical University School Of Medicine
-
Iwamoto Yasuhiko
Division Of Nephrology And Hypertension Department Of Medicine Diabetes Center Tokyo Women's Me
-
HANAI Ko
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of
-
NYUMURA Izumi
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of
-
TOYA Kiwako
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of
-
BOUCHI Ryotaro
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of
-
HAYASHI Toshihide
Division of Nephrology and Hypertension, Department of Medicine, Diabetes Center, Tokyo Women's Medi
-
Hayashi Toshihide
Division Of Nephrology And Hypertension Department Of Medicine Diabetes Center Tokyo Women's Me
-
Hanai Ko
Division Of Nephrology And Hypertension Diabetes Center Tokyo Women's Medical University School
-
Toya Kiwako
Division Of Nephrology And Hypertension Diabetes Center Tokyo Women's Medical University School
-
Nyumura Izumi
Division Of Nephrology And Hypertension Diabetes Center Tokyo Women's Medical University School
-
Bouchi Ryotaro
Division Of Nephrology And Hypertension Diabetes Center Tokyo Women's Medical University School
-
YOSHIDA Naoshi
Division of Nephrology and Hypertension, Department of Medicine, Diabetes Center, Tokyo Women's Medi
-
TANAKA Nobue
Division of Nephrology and Hypertension, Department of Medicine, Diabetes Center, Tokyo Women's Medi
-
ISHII Akiko
Division of Nephrology and Hypertension, Department of Medicine, Diabetes Center, Tokyo Women's Medi
-
Ishii Akiko
Division Of Nephrology And Hypertension Department Of Medicine Diabetes Center Tokyo Women's Me
-
Tanaka Nobue
Division Of Nephrology And Hypertension Department Of Medicine Diabetes Center Tokyo Women's Me
-
Yoshida Naoshi
Division Of Nephrology And Hypertension Department Of Medicine Diabetes Center Tokyo Women's Me
-
Babazono Tetsuya
The Diabetes Center Tokyo Women's Medical University
関連論文
- Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus
- Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes : A Post-Hoc Analysis of the Incipient to Overt : Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVA
- Pulse Pressure and Chronic Kidney Disease in Patients with Type 2 Diabetes
- Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy
- Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes?
- Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes
- Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes
- Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes
- Comparative evaluation of angiotensin II receptor blockers on HOMA-R and adiponectin release in hypertensive patients with mild type 2 diabetes
- Leptin mediates the relationship between abdominal obesity and microalbuminuria in type 2 diabetic patients
- Administration of insulin glargine thrice weekly by medical staff at a dialysis unit : a new insulin regimen for diabetic management in physically impaired patients undergoing hemodialysis
- Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease : Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial